Clinical Trials Browser

Phase EARLY_PHASE1 × Terminated × Melanoma × Clear all

NCT03893019 2024-05-16

MB-CART20.1 Melanoma

Phase EARLY_PHASE1 Terminated

Melanoma

NCT04663126 2023-12-13

Tilmanocept

Phase EARLY_PHASE1 Terminated

Melanoma

NCT02382549 2023-12-12

Mel61

Phase EARLY_PHASE1 Terminated

Melanoma

NCT03060356 2023-06-22

Autologous T Cells Expressing MET scFv CAR (RNA CART-cMET)

Phase EARLY_PHASE1 Terminated

BreastDermatologic

Breast Neoplasms, Melanoma

NCT02591654 2022-12-30

MPAK

Phase EARLY_PHASE1 Terminated

Melanoma, Neoplasm Metastasis

NCT03526185 2022-07-25

A Pilot Study Using Short-Term Cultured Anti-Tumor Autologous Lymphocytes

Phase EARLY_PHASE1 Terminated

Melanoma

NCT03338777 2020-02-25

IGTM-101

Phase EARLY_PHASE1 Terminated

Melanoma

NCT03454243 2019-04-25

TITAN

Phase EARLY_PHASE1 Terminated

DermatologicGenitourinaryLymphoidThoracic

Carcinoma, Non-Small-Cell Lung, Carcinoma, Squamous Cell, Carcinoma, Transitional Cell, Hodgkin Disease, Melanoma

NCT00499733 2019-01-18

Cyclophosphamide and Cryoablation in Treating Patients With Advanced or Metastatic Epithelial Cancer

Phase EARLY_PHASE1 Terminated

BreastCNSDermatologicGastrointestinalGenitourinaryHead & NeckLymphoidSarcomaThoracic

Squamous Cell Carcinoma of Head and Neck, Uveal Melanoma, Breast Neoplasms, Carcinoma, Non-Small-Cell Lung, Carcinoma, Renal Cell, Chondrosarcoma, Colonic Neoplasms, Carcinoma, Hepatocellular, Melanoma, Neoplasms, Neoplasms, Unknown Primary, Pancreatic Neoplasms, Prostatic Neoplasms, Salivary Gland Neoplasms, Sarcoma, Osteosarcoma, Tongue Neoplasms, Neuroectodermal Tumors, Primitive, Peripheral, Esthesioneuroblastoma, Olfactory, Breast Neoplasms, Male, Small Cell Lung Carcinoma, Intraocular Lymphoma

NCT00871533 2017-08-04

Pilot Study of IFN α2b for Melanoma Patients

Phase EARLY_PHASE1 Terminated

Melanoma

NCT02442466 2015-05-20

Proof of Concept Study With an Endothelin Receptor B Inhibitor (BQ-788) for Human Melanoma

Phase EARLY_PHASE1 Terminated

Melanoma